The START Center's News - Cancer Research and Treatment Information

START ESMO IO Activity

2022 ESMO IMMUNO-ONCOLOGY (ESMO IO) ACTIVITY SUMMARY The START Center investigators contributed as authors to posters and abstracts at...

START SITC Activity

2022 SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) ACTIVITY SUMMARY The START Center investigators contributed as authors to posters and...

2022 EORTC-NCI-AACR ACTIVITY SUMMARY

2022 EORTC-NCI-AACR ACTIVITY SUMMARY The START Center investigators contributed as authors to posters and abstracts at this year's...

Exelixis Announces Initial Dose-Escalation Results from the First-in-Human Phase 1 Trial Evaluating

ALAMEDA, Calif.--(BUSINESS WIRE)--Dec. 8, 2022-- Exelixis, Inc. (Nasdaq: EXEL) today announced initial results from the ongoing...

START Center for Cancer Care to Open New Locations in Lisbon and Dublin

First oncology early-phase clinical trials units in Portugal and Ireland to offer leading-edge cancer treatments --(BUSINESS WIRE)-- SAN...

Dr. Jay Messer Prostate Cancer Interview on kens5

See Dr. Jay Messer's interview on kens5 as part of National Prostate Cancer Awareness Month. Prostate Cancer Treatment Services | Great...